Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil H Shear

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|May 1, 2007
Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamidesManuela G Neuman, Neil H Shear, Izabella M Malkiewicz, et al.
Clinical Therapeutics|May 28, 2018
Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION StudyJohn K Marshall, Louis Bessette, Neil H Shear, et al.
Romanian Journal of Gastroenterology|July 30, 2002
Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapyManuela G Neuman, Jean-Pierre Benhamou, Asma Ibrahim, et al.
Clinical Therapeutics|March 10, 2018
Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort StudyJohn K Marshall, Louis Bessette, Carter Thorne, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2018
Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical TrialsNeil H Shear, Carle Paul, Andrew Blauvelt, et al.
Scientometrics|April 10, 2023
Measuring h-index and scholarly productivity in academic dermatology in CanadaMarleine Azar, Francois Lagacé, Anastasiya Muntyanu, et al.
Drug Safety|October 21, 2017
Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisCristina Olteanu, Neil H Shear, Hall F Chew, et al.
Journal of the American Academy of Dermatology|February 9, 2016
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])Bruce E Strober, Robert Bissonnette, David Fiorentino, et al.
Dermatology and Therapy|September 12, 2021
Practical Management of Patients with Atopic Dermatitis on DupilumabKim A Papp, Chih-Ho Hong, M Perla Lansang, et al.
European Journal of Clinical Pharmacology|June 30, 2019
Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvementJennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Translational Research : the Journal of Laboratory and Clinical Medicine|May 1, 2007
Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamidesManuela G Neuman, Neil H Shear, Izabella M Malkiewicz, et al.
Clinical Therapeutics|May 28, 2018
Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION StudyJohn K Marshall, Louis Bessette, Neil H Shear, et al.
Romanian Journal of Gastroenterology|July 30, 2002
Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapyManuela G Neuman, Jean-Pierre Benhamou, Asma Ibrahim, et al.
Clinical Therapeutics|March 10, 2018
Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort StudyJohn K Marshall, Louis Bessette, Carter Thorne, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2018
Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical TrialsNeil H Shear, Carle Paul, Andrew Blauvelt, et al.
Scientometrics|April 10, 2023
Measuring h-index and scholarly productivity in academic dermatology in CanadaMarleine Azar, Francois Lagacé, Anastasiya Muntyanu, et al.
Drug Safety|October 21, 2017
Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisCristina Olteanu, Neil H Shear, Hall F Chew, et al.
Journal of the American Academy of Dermatology|February 9, 2016
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])Bruce E Strober, Robert Bissonnette, David Fiorentino, et al.
Dermatology and Therapy|September 12, 2021
Practical Management of Patients with Atopic Dermatitis on DupilumabKim A Papp, Chih-Ho Hong, M Perla Lansang, et al.
European Journal of Clinical Pharmacology|June 30, 2019
Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvementJennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
Pageof 20